Obesity Phenotyping in Children and Adolescents: Next Steps Towards Precision Medicine in Pediatric Obesity

Leslie Saba1, Andres J Acosta2, Aaron S Kelly3

  • 1Division of Pediatric Endocrinology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Nutrients
|January 28, 2026
PubMed

Insights

Pediatric obesity treatment varies greatly. Identifying specific patient characteristics is crucial for developing personalized interventions and improving weight management outcomes in children and adolescents.

Area of Science:

  • Pediatric Endocrinology
  • Obesity Medicine
  • Metabolic Disorders

Background:

  • Pediatric obesity is a growing, complex health issue with diverse treatment responses.
  • Current interventions for childhood obesity often face challenges in achieving sustained weight reduction.
  • Understanding factors influencing treatment variability is key to improving outcomes.

Purpose of the Study:

  • To review evidence on outcome variability in pediatric obesity interventions.
  • To examine biological, metabolic, behavioral, environmental, and psychosocial factors affecting treatment response.
  • To highlight the need for obesity phenotyping in pediatric populations.

Main Methods:

  • Systematic review of current literature on pediatric obesity interventions.
  • Analysis of factors influencing treatment effectiveness across lifestyle, pharmacologic, and surgical approaches.
  • Comparison with adult obesity phenotyping strategies.

Main Results:

  • Significant heterogeneity exists in treatment responses for pediatric obesity.
  • Limited data are available on obesity phenotyping in children and adolescents.
  • Adult phenotyping models show promise but require pediatric validation.

Conclusions:

  • Personalized medicine approaches are essential for effective pediatric obesity management.
  • Developing pediatric-specific obesity phenotypes can guide tailored interventions.
  • Addressing phenotyping gaps will enhance treatment selection and long-term outcomes.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.3K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
254
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
266
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
176
Cognitive Development During Adolescence01:18

Cognitive Development During Adolescence

During adolescence, individuals experience significant cognitive development that enhances their understanding of others' emotions and thoughts, known as cognitive empathy. This period is marked by an increased ability to adapt to others' perspectives and a more nuanced understanding of others' mental states, a skill that is foundational for social problem-solving and conflict avoidance. The development of cognitive empathy relies heavily on the theory of mind — the...
579
Uncertainty in Measurement: Accuracy and Precision03:37

Uncertainty in Measurement: Accuracy and Precision

Scientists typically make repeated measurements of a quantity to ensure the quality of their findings and to evaluate both the precision and the accuracy of their results. Measurements are said to be precise if they yield very similar results when repeated in the same manner. A measurement is considered accurate if it yields a result that is very close to the true or the accepted value. Precise values agree with each other; accurate values agree with a true value. 
100.9K